N4 Pharma Plc (AIM:N4P)
London
· Delayed Price · Currency is GBP · Price in GBX 0.4750
+0.0250 (5.26%)
Jun 6, 2025, 4:35 PM GMT+1
N4 Pharma Revenue
In the year 2024, N4 Pharma had annual revenue of 7.28K GBP with 272.86% growth. N4 Pharma had revenue of 3.91K in the half year ending June 30, 2024.
Revenue
7.28K
Revenue Growth
+272.86%
P/S Ratio
542.89
Revenue / Employee
1.46K
Employees
5
Market Cap
3.95M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |